Prostate imaging in malignant and benign conditions Aaron SulmanMartin I. Resnick Invited Commentary Pages: 1 - 3
A randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2/interferon Ken-ryu HanAllan J. PantuckArie S. Belldegrun Clinical Trials Report Pages: 11 - 12
Minimally invasive ablative approaches in the treatment of renal cell carcinoma Nicolette JanzenAmnon ZismanArie S. Belldegrun OriginalPaper Pages: 13 - 20
Laparoscopic radical nephrectomy for advanced kidney cancer Stephen E. PaulterMcClellan M. Walther OriginalPaper Pages: 21 - 24
Kidney pathology: Current classification of renal cell carcinoma Jonathan W. SaidGeorge ThomasAmnon Zisman OriginalPaper Pages: 25 - 30
Prognostic factors for biologic therapy in kidney cancer Beverly J. Drucker OriginalPaper Pages: 31 - 36
Surgical management of renal cell carcinoma invading the vena cava Matthew T. GettmanMichael L. Blute OriginalPaper Pages: 37 - 43
The role of adjuvant immunotherapy in renal cell carcinoma Peter F. A. MuldersPieter H. M. de Mulder OriginalPaper Pages: 44 - 49
Sacral neuromodulation for the treatment of bladder dysfunction Jennifer MaLossiToby C. Chai OriginalPaper Pages: 61 - 66
A novel method for the analysis of the androgen receptor Kris E. GastonO. Harris Ford IIIJames L. Mohler OriginalPaper Pages: 67 - 74
Immune gene therapy in urology Ingo KauschPeter ArdeltTimothy L. Ratliff OriginalPaper Pages: 82 - 89